Uses of Praxinstad

Praxinstad medicine has the main ingredient Moxifloxacin and other excipients. Praxinstad is prescribed by a doctor and is used in the treatment of community-acquired pneumonia, skin infections,...

Praxinstad medicine has the main ingredient Moxifloxacin (in the form of Moxifloxacin HCl) 400mg and other excipients just enough for 1 tablet.
Praxinstad is used in the following cases:
Treatment of mild to moderate community-acquired pneumonia caused by bacteria H. influenzae, Streptococcus pneumoniae, Chlamydia pneumoniae, Moraxella catarrhalis or Mycoplasma pneumoniae. Treatment of skin and subcutaneous soft tissue infections caused by Streptococcus pyogenes and Staphylococcus aureus. Praxinstad is effective in the treatment of skin infections such as cellulitis, uncomplicated subcutaneous abscess, boils, impetigo. Treatment of acute infectious episodes of chronic bronchitis caused by Streptococcus pneumoniae, Klebsiella pneumoniae, Haemophilus influenzae, H. Parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus. Since severe damage and acute bacterial exacerbations of chronic bronchitis may resolve spontaneously in some patients, moxifloxacin should be used only in patients with no alternative treatment options. Acute sinusitis caused by susceptible bacteria Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis: fluoroquinolone antibiotics, including moxifloxacin, have been associated with serious adverse reactions and acute bacterial sinusitis in some patients with If the disease resolves spontaneously, moxifloxacin should only be used in patients who have no alternative treatment options. Praxinstad should not be used in the following cases:
Patients with hypersensitivity, history of allergy to moxifloxacin, other quinolones, or to any ingredient in Praxinstad. Children under 18. The patient has a prolonged QT interval and is taking class IA (procainamide, quinidine) or class III (sotalol, amiodarone) antiarrhythmic drugs.

Praxinstad can be taken before, during or after a meal. Reference dosage of Praxinstad is as follows:
The usual dose of Moxifloxacin is 400mg x 1 time/day. Duration of treatment: 10 days for patients with acute bacterial sinusitis, mild and moderate community-acquired pneumonia; 7 days for patients with skin and subcutaneous tissue infections; 5 days for patients with acute infectious episodes of chronic bronchitis. Renal and hepatic impairment: No dose adjustment of Moxifloxacin is required for patients with mild to moderate renal/liver impairment and the elderly. Moxifloxacin has not been studied in patients with renal failure undergoing hemodialysis or in patients with severe hepatic impairment. Or use Praxinstad as directed by your doctor.

During the use of Praxinstad, patients may experience some unwanted side effects such as:
Common: Vomiting, diarrhea, dizziness.
Uncommon
Abdominal pain, indigestion, dry mouth, mild taste disturbance. Headache, tremors, convulsions, depression, confusion, insomnia, somnolence, restlessness, anxiety. Itching, erythema. Increased amylase Increased lactate dehydrogenase. Joint pain, muscle pain. Rare
QT interval prolongation. Tendon rupture and Achilles tendon rupture. Diarrhea caused by C.difficile. Hallucinations, suicidal thoughts, vision disturbances, depression. Patients should inform their doctor about any side effects encountered while taking Praxinstad.

Praxinstad should be used with caution with some other drugs that can cause QT prolongation such as cisapride, erythromycin, antipsychotics, tricyclic antidepressants. It has been reported that moxifloxacin may cause prolongation of the QT interval on the electrocardiogram. Moxifloxacin should also be used with caution in patients with cardiac arrhythmias including bradycardia and acute myocardial ischemia.
Use caution when using Praxinstad in patients with central nervous system diseases such as epilepsy, severe cerebral arteriosclerosis because it can cause convulsions.
Serious potentially disabling and irreversible adverse reactions include: tendon rupture, tendinitis, peripheral neuropathy and CNS adverse effects.
Commonly reported adverse reactions including tendon rupture, tendonitis, arthralgia, myalgia, peripheral neuropathy, depression, hallucinations, anxiety, insomnia, headache heavy and confused. Patients of any age or without pre-existing risk factors may experience these adverse reactions.
Stop using Praxinstad at the first sign or symptom of any serious adverse reaction. In addition, avoid the use of fluoroquinolone antibiotics in patients who have experienced serious fluoroquinolone-related reactions.
Because of the great risk of harm to the fetus when using moxifloxacin during pregnancy, the use of Praxinstad is not recommended.
There have been reports that moxifloxacin is distributed into breast milk, so Praxinstad should not be used in nursing mothers because it may cause harm to infants. In cases where it is necessary to use it, it is necessary to carefully consider the potential benefits to outweigh the potential risks or to discontinue breast-feeding while taking Praxinstad.
There have been no reports of moxifloxacin affecting the ability to drive and use machines. However, the side effects of Praxinstad can be nerve effects such as dizziness or fainting. Patients should be instructed to recognize reactions to Praxinstad before driving or operating machinery.